Differential gene expression profiling in genetic and multifactorial cardiovascular diseases
Luisa Nanni1, Chiara Romualdi, Attilio Maseri
1Clinical Cardiovascular Biology Research Center, Vita-Salute San Raffaele University, Milano, Italy.
Journal of Molecular and Cellular Cardiology
|October 6, 2006
Summary
Microarray gene expression profiling reveals molecular insights into cardiovascular diseases. This approach aids in classifying patients and identifying new prognostic and therapeutic markers for heart conditions.
Area of Science:
- Cardiovascular Research
- Genomics
- Molecular Biology
Background:
- Gene expression profiling using microarrays is a powerful tool for understanding transcriptional changes in cardiovascular disorders.
- Studies in human cardiovascular syndromes and animal models aim to elucidate complex molecular pathophysiology.
- Similar to cancer research, gene expression studies can refine patient classification and identify novel prognostic/therapeutic markers in cardiology.
Purpose of the Study:
- To review genomic findings from microarray platforms exploring transcriptome alterations in cardiovascular diseases.
- To highlight the potential of global gene expression profiling in understanding heart diseases.
- To present findings from both genetic and multifactorial cardiovascular disorders, including relevant animal and cellular models.
Main Methods:
- Utilizing microarray technologies to analyze gene expression patterns.
- Reviewing genomic data from human patients and animal models of cardiovascular diseases.
- Focusing on classic genetic heart diseases (e.g., hypertrophic cardiomyopathy, Fabry disease) and common multifactorial conditions (e.g., heart failure, atherosclerosis, infarction).
Main Results:
- Microarray analysis has successfully identified transcriptional changes in various cardiovascular conditions.
- Genomic findings provide insights into the molecular basis of both inherited and acquired heart diseases.
- Data from human studies are complemented by findings from corresponding animal and cellular models, offering a comprehensive view.
Conclusions:
- Gene expression profiling via microarrays offers significant potential for advancing cardiovascular research.
- This approach can lead to improved molecular classification of cardiovascular diseases.
- Identification of new diagnostic and therapeutic targets is a key outcome of these genomic studies.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...